Building Cross Disciplinary Teams to Bring Futuristic Solutions with Dr. Jack Kreindler

Minter Dialogue Episode #301 Dr Jack Kreindler is a Doctor, Technologist, Investor. Founder CHHP - The Centre for Health and Human Performance, based in London. He's also the founder (Chairman and Chief Medical Officer) of Sentrian, working to finally make remote patient management an affordable and effective reality for patients, payers and providers alike. And, also of note, he's co-Founder of Weird and Wonderful, building bridges across life sciences and creative arts. In this sprawling conversation with polymath Jack, we discuss how we can learn more about our own health and cure cancer studying high performance and extreme athletes. We learn about how Jack manages and collaborates across large multi-disciplinarian teams to pave trails, as well as what technologies excite him. Divinely intriguing. Meanwhile, please send me your questions as an audio file (or normal email) to nminterdial@gmail.com; or you can find the show notes and comment on minterdial.com. If you liked the podcast, please take a moment to go over to iTunes to rate/review the podcast. Otherwise, you can find me @mdial on Twitter.  Support the show (https://www.patreon.com/minterdial)

Om Podcasten

With the Minter Dialogue podcast, your host Minter Dial is on a mission to help elevate the debate and insert more meaningfulness into our lives. He gives weekly interviews around leadership, brand strategy and transformation, featuring top business leaders, personalities, entrepreneurs and authors from around the world who are making things happen! The show was ranked as the #6 Leadership and #5 Branding Podcast 2021 by Feedspot, Julie Livingstone’s Top 15 Marketing Podcasts 2020 and Top 50 Marketing Blog/Podcasts by Linkedin. Minter Dial is a filmmaker and author of multiple award-winning books, including The Last Ring Home, Futureproof (FT Press), You Lead (Kogan Page) and Heartificial Empathy, 2nd edition (2023). Podcast show notes are on minterdial.com. To rate & review: RateThisPodcast.